Tomita Y, Khan A, Sykes M
Transplantation Biology Research Center, Massachusetts General Hospital, Harvard Medical School, Boston 02129, USA.
Transplantation. 1996 Feb 15;61(3):477-85. doi: 10.1097/00007890-199602150-00028.
A relatively nontoxic method of conditioning mice has been developed recently that allows allogeneic bone marrow engraftment and specific skin allograft tolerance induction. This regiment included anti-CD4 and anti-CD8 mAbs administered on day -5, followed by 3-Gy whole body irradiation (WBI) and 7-Gy thymic irradiation (TI) on day 0. We have recently shown that the potential toxicity of this regimen can be further reduced by replacing TI with additional anti-T cell mAb injections before and after bone marrow transplantation. Mixed chimerism and prolonged donor-specific skin graft acceptance are induced in 90% of B10 mice conditioned with anti-CD4 and anti-CD8 mAbs on days -6 and -1 and 3-Gy WBI on day 0 without TI, but only in a small fraction of mice receiving a similar regimen, except that mAbs are given on day -5 only. To determine the mechanism of tolerance induction in the former group, we compared the two groups for the extent of thymocyte depletion, for the timing of development of intrathymic and extrathymic chimerism, and for clonal deletion of host-type thymocytes with TCR recognizing superantigens presented by donor class II molecules. The results suggest that administration of a second mAb injection depletes or inactivates residual host thymocytes that are capable of causing intrathymic rejection of donor hematopoietic cells even when peripheral engraftment is achieved. The presence of donor class II+ hematopoietic cells in the thymus on day 14 correlated with marked deletion of mature host-type V beta 11+ thymocytes that recognize donor I-E plus endogenous superantigen. This suggests that tolerance is achieved primarily through a central deletional mechanism when peripheral and intrathymic host T cells are adequately inactivated or depleted by mAbs and 3-Gy WBI. In addition, the higher incidence of early failure of peripheral chimerism in mice conditioned with a single injection rather than than two mAb injections prior to bone marrow transplantation suggests that nontolerant residual host thymocytes can also induce early peripheral rejection after mAbs have cleared from the circulation. This early rejection is prevented by the longer persistence of anti-T cell mAbs observed in mice receiving two pretransplant mAb injections. Thus, administration of sufficient depleting anti-T cells mAbs followed by 3-Gy WBI allows the induction of central deletional tolerance while minimizing the toxicity of the conditioning regimen.
最近开发了一种相对无毒的小鼠预处理方法,该方法可实现同种异体骨髓移植并诱导特异性皮肤同种异体移植耐受。该方案包括在第-5天给予抗CD4和抗CD8单克隆抗体,随后在第0天进行3 Gy全身照射(WBI)和7 Gy胸腺照射(TI)。我们最近表明,通过在骨髓移植前后用额外的抗T细胞单克隆抗体注射替代TI,可以进一步降低该方案的潜在毒性。在第-6天和第-1天用抗CD4和抗CD8单克隆抗体预处理、第0天进行3 Gy WBI且不进行TI的情况下,90%的B10小鼠诱导出混合嵌合体并延长了供体特异性皮肤移植的接受时间,但在接受类似方案(除了仅在第-5天给予单克隆抗体)的小鼠中只有一小部分出现这种情况。为了确定前一组中耐受诱导的机制,我们比较了两组的胸腺细胞耗竭程度、胸腺内和胸腺外嵌合体形成的时间,以及用识别供体II类分子呈递的超抗原的TCR对宿主型胸腺细胞进行克隆清除的情况。结果表明,第二次注射单克隆抗体可耗尽或使残余的宿主胸腺细胞失活,即使在外周实现移植后,这些胸腺细胞仍能够引起胸腺内对供体造血细胞的排斥反应。第14天时胸腺中供体II类+造血细胞的存在与识别供体I-E加内源性超抗原的成熟宿主型Vβ11+胸腺细胞的显著缺失相关。这表明,当外周和胸腺内的宿主T细胞通过单克隆抗体和3 Gy WBI充分失活或耗竭时,主要通过中枢性删除机制实现耐受。此外,在骨髓移植前用单次注射而非两次注射单克隆抗体预处理的小鼠中,外周嵌合体早期失败的发生率更高,这表明在单克隆抗体从循环中清除后,未耐受的残余宿主胸腺细胞也可诱导早期外周排斥反应。接受两次移植前单克隆抗体注射的小鼠中观察到的抗T细胞单克隆抗体的更长持续时间可防止这种早期排斥反应。因此,给予足够的耗竭性抗T细胞单克隆抗体并随后进行3 Gy WBI可诱导中枢性删除耐受,同时将预处理方案的毒性降至最低。